BMY vs PFE
BMY and PFE side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BMYBristol-Myers Squibb Company | PFEPfizer Inc. |
|---|---|---|
| Market cap | $118.66B | $138.55B |
| P/E (TTM) | 16.3 | 18.6 |
| P/B | 5.91 | 1.54 |
| Dividend yield | — | 7.05% |
| Revenue | $48.48B(TTM) | $63.31B(TTM) |
| Net income | $7.28B(TTM) | $7.49B(TTM) |
| EPS, diluted | $3.57(TTM) | $1.31(TTM) |
Figures from SEC filings · for reference only · not investment advice
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)